Does ALPROSTADIL Cause Injection site discolouration? 5 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site discolouration have been filed in association with ALPROSTADIL (Edex). This represents 0.2% of all adverse event reports for ALPROSTADIL.
5
Reports of Injection site discolouration with ALPROSTADIL
0.2%
of all ALPROSTADIL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site discolouration From ALPROSTADIL?
Of the 5 reports.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPROSTADIL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ALPROSTADIL Cause?
Drug ineffective (1,412)
Wrong technique in product usage process (510)
Product quality issue (227)
Penile pain (164)
Off label use (112)
Penile burning sensation (92)
Erection increased (75)
Penile haemorrhage (62)
No adverse event (60)
Injection site pain (57)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
Which ALPROSTADIL Alternatives Have Lower Injection site discolouration Risk?
ALPROSTADIL vs ALTEPLASE
ALPROSTADIL vs ALTERNARIA ALTERNATA
ALPROSTADIL vs ALTHIAZIDE
ALPROSTADIL vs ALTHIAZIDE\SPIRONOLACTONE
ALPROSTADIL vs ALUMINUM